Site disruption

We are doing some essential maintenance work and you will not be able to register or update your profile setting until we've finished, which should be at about 9pm this evening.

We apologise for any inconvenience - you will be able to register shortly. In the mean time you will still be able to log in as usual.

Anti-cancer pioneers

Published on
March 9, 2007
Last updated
May 22, 2015

Two Dundee University mathematicians have been awarded £160,000 by the Engineering and Physical Sciences Research Council to develop a new breed of "targeted" anti-cancer drugs. Fordyce Davidson and Mark Chaplain will work with biotechnology company Cyclacel Pharmaceuticals Inc.

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please
or
to read this article.

Sponsored

Featured jobs

See all jobs
ADVERTISEMENT